May 5 (Reuters) - The Trump Administration said on Tuesday its "Most Favored Nation" (MFN) drug pricing deal was expected to ...

Medicare negotiated the price of 10 popular medications to save enrollees money. Even more medications are scheduled for ...

With Regeneron's recent deal, all 17 targeted pharmaceutical giants are now part of the TrumpRx program. Learn how it works ...

President Donald Trump on Thursday announced a deal with drugmaker Regeneron to lower the cost of its pharmaceutical products ...

Forbes contributors publish independent expert analyses and insights. Sally Pipes is a scholar and think tank CEO who writes on health care. "Competition is leading to lower prices, better value, and ...

In early 2026, all 16 drugmakers that signed price-cut agreements with the Trump administration also raised prices on hundreds of brand-name drugs, with median hikes of 4%. While TrumpRx offers select ...

The GENEROUS Model aims to reduce Medicaid drug costs by aligning prices with international standards, launching in 2026. It builds on existing programs like the Medicaid Drug Rebate Program and the ...

Three Republican senators voted in support of an amendment sponsored by Sen. Bernie Sanders (I-Vt.) early Thursday morning to ...

On Thursday, President Donald Trump announced a new drug price deal with Regeneron, the latest company to agree to a new ...

Maris is a six-time No. 1 ranked pharmaceutical analyst with more than two decades covering the industry. A month’s supply of Miebo, Bausch & Lomb’s prescription dry eye drug, costs $800 or more in ...